XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 35 filers reported holding XENON PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $127,000 | -14.2% | 8,293 | 0.0% | 0.05% | +12.8% |
Q2 2021 | $148,000 | 0.0% | 8,293 | 0.0% | 0.05% | +20.5% |
Q1 2021 | $148,000 | +15.6% | 8,293 | 0.0% | 0.04% | +143.8% |
Q4 2020 | $128,000 | +39.1% | 8,293 | 0.0% | 0.02% | -40.7% |
Q3 2020 | $92,000 | -11.5% | 8,293 | 0.0% | 0.03% | -68.6% |
Q2 2020 | $104,000 | +10.6% | 8,293 | 0.0% | 0.09% | -13.1% |
Q1 2020 | $94,000 | -13.8% | 8,293 | 0.0% | 0.10% | +110.6% |
Q4 2019 | $109,000 | +45.3% | 8,293 | 0.0% | 0.05% | +62.1% |
Q3 2019 | $75,000 | -8.5% | 8,293 | 0.0% | 0.03% | +11.5% |
Q2 2019 | $82,000 | -2.4% | 8,293 | 0.0% | 0.03% | -66.2% |
Q1 2019 | $84,000 | +61.5% | 8,293 | 0.0% | 0.08% | +5.5% |
Q4 2018 | $52,000 | -52.3% | 8,293 | 0.0% | 0.07% | +37.7% |
Q3 2018 | $109,000 | +43.4% | 8,293 | 0.0% | 0.05% | +65.6% |
Q2 2018 | $76,000 | +230.4% | 8,293 | 0.0% | 0.03% | +220.0% |
Q1 2018 | $23,000 | 0.0% | 8,293 | 0.0% | 0.01% | +25.0% |
Q4 2017 | $23,000 | -4.2% | 8,293 | 0.0% | 0.01% | +33.3% |
Q3 2017 | $24,000 | -7.7% | 8,293 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $26,000 | -21.2% | 8,293 | 0.0% | 0.01% | -14.3% |
Q1 2017 | $33,000 | -98.7% | 8,293 | -97.4% | 0.01% | -98.8% |
Q4 2016 | $2,465,000 | – | 320,061 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |